REQUEST A DEMO
Total
USD $0.00
Search more companies

Qurient Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Qurient Co., Ltd. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Qurient Co., Ltd is a biotech company. The company focuses on conducting clinical trials in various disease indications and has introduced a unique virtual biotech model called 'Network R&D' and has brought two drug candidates to the global clinical development stage. Qurient aims to provide innovation for unmet medical needs to help patients around the world.

Headquarters
8F, C Dong, 242, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi; Postal Code: 13487

Contact Details: Purchase the Qurient Co., Ltd. report to view the information.

Website: http://www.qurient.com

Basic Information
Total Employees:
Purchase the Qurient Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Qurient Co., Ltd. report to view the information.
Registered Capital:
Purchase the Qurient Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Qurient Co., Ltd. report to view the information.
Incorporation Date:
July 02, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
11.4%
Purchase this report to view the information.
8.3%
Purchase this report to view the information.
2.4%
Subsidiaries
Qli5 Therapeutics Gmbh
Company Performance
Financial values in the chart are available after Qurient Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-1.73%
Total operating revenue
-0.95%
Operating profit (EBIT)
20.55%
EBITDA
21.14%
Net Profit (Loss) for the Period
21.44%
Total assets
44.82%
Total equity
54.83%
Operating Profit Margin (ROS)
64.04%
Net Profit Margin
64.09%
Return on Equity (ROE)
11.69%
Debt to Equity Ratio
-2.01%
Quick Ratio
9.99%
Cash Ratio
10.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?